Skip to content

Eye Health Center

Font Size

Gene Therapy May Help Against Rare Blinding Disease

Early study saw improvement in six patients with choroideremia


Six months after the operation, patients with good or excellent vision retained that vision but could see more in the dark when tested. Loss of night vision is an early sign of the disease, MacLaren said.

The two patients with bad vision experienced improvement, and were now able to read two and four more lines on a sight chart.

Those improvements have lasted for two years in one patient and one year in the other, researchers reported.

"It's too early to say the degeneration has stopped, but the vision we've seen in these two patients has been sustained at one year and two years," MacLaren said in an interview.

Fromer said that the most promising part about gene therapy for eye diseases is that vision loss often occurs very slowly. That means that doctors would have ample time to halt vision loss using a genetic cure.

"You have a lot of time to get that virus into the eye, to correct the defective gene," Fromer said. "The window is large."

MacLaren said this research has focused on choroideremia because it is a relatively simple disease caused by just one defective gene.

By proving this type of treatment can work, he added, doctors can then investigate using it to treat more complicated genetic eye disorders in which multiple genes are malfunctioning.

"This is effectively the first flight across the Atlantic," MacLaren said. "It's one disease, it's quite rare, but it represents a big step forward."


Today on WebMD

Woman holding tissue to reddened eye
Learn about causes, symptoms, and treatments.
Simple annoyance or the sign of a problem?
red eyes
Symptoms, triggers, and treatments.
blue eye with contact lens
Tips for wearing and caring.
Understanding Stye
human eye
eye exam timing
vision test
is vision correction surgery for you
high tech contacts
eye drop

Special Sections